UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Aug 10, 2026
Sale
Calculated transaction value
$375.16K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Aug 7, 2026
Public filing date
Aug 10, 2026
Filing lag
Filed 3 days later
UTHR daily price context
Close on/before transaction
$538.84
Aug 7, 2026
Close before public filing
$538.84
Aug 7, 2026
Return since public filing
-7.74%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 709 shares @ $529.14
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000116
Filing cohort
Transactions in this filing
Showing 15 of 17
Trades
17
Issuers
1
Estimated value
$6.33M
Buys / sales
0 / 15
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 7, 2026 | $1.29M |
| United Therapeutics Corp UTHR | Sale | Aug 7, 2026 | $85.34K |
| United Therapeutics Corp UTHR | Sale | Aug 7, 2026 | $85.65K |
| United Therapeutics Corp UTHR | Sale | Aug 7, 2026 | $216.52K |
| United Therapeutics Corp UTHR | Sale | Aug 7, 2026 | $768.96K |
| United Therapeutics Corp UTHR | Sale | Aug 7, 2026 | $336.59K |
| United Therapeutics Corp UTHR | Sale | Aug 7, 2026 | $340.74K |
| United Therapeutics Corp UTHR | Sale | Aug 7, 2026 | $187.53K |
| United Therapeutics Corp UTHR | Sale | Aug 7, 2026 | $585.08K |
| United Therapeutics Corp UTHR | Sale | Aug 7, 2026 | $126.65K |
| United Therapeutics Corp UTHR Current | Sale | Aug 7, 2026 | $375.16K |
| United Therapeutics Corp UTHR | Sale | Aug 7, 2026 | $1.48M |
| United Therapeutics Corp UTHR | Sale | Aug 7, 2026 | $97.36K |
| United Therapeutics Corp UTHR | Sale | Aug 7, 2026 | $106.85K |
| United Therapeutics Corp UTHR | Sale | Aug 7, 2026 | $193.32K |